Anti‐Inflammatory Nanotherapies Based on Bioactive Cyclodextrin Materials
Authors:
Open Access
- 21 November 2023
- journal article
- review article
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 3 (12)
Abstract
Despite remarkable advances in understanding the mechanisms underlying inflammation, the currently available anti‐inflammatory therapies have many limitations, such as poor efficacies, low selectivity, and severe adverse effects. Bioactive materials with intrinsically anti‐inflammatory activities have emerged as promising drug candidates for the treatment of inflammatory disorders. Among them, nanotherapies based on bioactive cyclodextrin (CD) materials have attracted much attention, owing to their multiple advantages, including broad availability, well‐controlled structures, easy functionalization, good processibility, high cost‐effectiveness, and excellent biocompatibility. This review provides a comprehensive overview of the recent advancements in the development and applications of anti‐inflammatory nanoparticles (NPs) based on bioactive CD materials, with special focus on reactive oxygen species‐scavenging NPs and NPs capable of regulating inflammatory cell recruitment and activation. In addition, the applications of these anti‐inflammatory nanotherapies in the treatment of different acute/chronic inflammatory diseases are highlighted. Furthermore, major challenges in the clinical translation of these new generation anti‐inflammatory therapies derived from bioactive CD materials are discussed.Keywords
Funding Information
- National Natural Science Foundation of China (82170565, 32271451)
This publication has 210 references indexed in Scilit:
- Nucleic acid-binding polymers as anti-inflammatory agentsProceedings of the National Academy of Sciences, 2011
- Optimized alkylated cyclodextrin polysulphates with reduced risks on thromboembolic accidents improve osteoarthritic chondrocyte metabolismRheumatology, 2011
- Dendritic polyglycerol sulfates as multivalent inhibitors of inflammationProceedings of the National Academy of Sciences, 2010
- Host–guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applicationsNano Today, 2010
- Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomasNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Sugammadex: Another Milestone in Clinical Neuromuscular PharmacologyAnesthesia & Analgesia, 2007
- Synthesis of New Prodrugs Based on β-CD as the Natural Compounds Containing β-lactam AntibioticsJournal of Bioactive and Compatible Polymers, 2007
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005British Journal of Pharmacology, 2006
- Oxidative Stress and Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Evolving concepts of rheumatoid arthritisNature, 2003